Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
13.48B | 14.57B | 14.71B | 12.93B | 13.31B | Gross Profit |
1.15B | 1.34B | 1.66B | 1.45B | 1.49B | EBIT |
170.13M | 225.32M | 797.28M | 575.90M | 593.35M | EBITDA |
589.00M | 670.92M | 1.26B | 1.03B | 1.03B | Net Income Common Stockholders |
229.76M | 212.22M | 613.52M | 474.02M | 435.80M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
3.57B | 3.61B | 3.54B | 3.46B | 2.48B | Total Assets |
11.53B | 11.64B | 12.17B | 10.56B | 10.07B | Total Debt |
139.24M | 287.40M | 493.57M | 131.04M | 231.73M | Net Debt |
-3.13B | -3.27B | -3.05B | -3.15B | -2.25B | Total Liabilities |
2.69B | 2.93B | 3.55B | 2.69B | 2.78B | Stockholders Equity |
8.84B | 8.72B | 8.62B | 7.87B | 7.30B |
Cash Flow | Free Cash Flow | |||
-89.74M | 659.36M | -248.10M | 1.08B | -1.24B | Operating Cash Flow |
371.37M | 858.75M | 191.41M | 1.15B | -419.16M | Investing Cash Flow |
-437.69M | -343.47M | -275.21M | -129.39M | -706.33M | Financing Cash Flow |
-217.68M | -497.49M | 338.63M | -109.24M | -169.92M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥3.53B | 5.38 | 2.26% | 22.30% | 19.46% | ||
79 Outperform | ¥3.89B | 8.01 | 3.69% | -9.83% | 33.02% | ||
78 Outperform | ¥3.39B | 8.84 | 3.42% | 9.34% | 174.40% | ||
72 Outperform | ¥4.49B | 16.72 | 2.59% | -7.48% | 9.38% | ||
72 Outperform | ¥8.04B | 15.95 | 2.32% | 7.06% | 38.55% | ||
66 Neutral | ¥3.54B | 12.72 | 3.08% | 8.39% | -35.48% | ||
66 Neutral | $4.47B | 12.22 | 5.40% | 3.65% | 4.14% | -12.00% |